Atomi Financial Group, Inc. Bridge Bio Pharma, Inc. Transaction History
Atomi Financial Group, Inc.
- $1.98 Trillion
- Q4 2024
A detailed history of Atomi Financial Group, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Atomi Financial Group, Inc. holds 14,302 shares of BBIO stock, worth $483,264. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,302Holding current value
$483,264% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
294Shares Held
170MCall Options Held
10.4MPut Options Held
2.36M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$854 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$849 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$480 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$421 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$205 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.01B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...